日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prevalence and characteristics of adults with atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation in the USA

美国成年人动脉粥样硬化性心血管疾病、慢性肾脏疾病和全身炎症的患病率和特征

Nanna, Michael G; Sloan, Lance A; Navar, Ann Marie; Faurby, Mads D; Husemoen, Lise Lotte N; Paul, Riyanka; Tombak, Gamze; Sattar, Naveed

LYMTACs:chimeric small molecules repurpose lysosomal membrane proteins for target protein relocalization and degradation.

LYMTACs:嵌合小分子可重新利用溶酶体膜蛋白,实现靶蛋白的重新定位和降解

Nalawansha Dhanusha A, Mazis Georgios, Husemoen Gitte, Ashton Kate S, Deng Weixian, Wurz Ryan P, Tran Anh T, Lanman Brian A, Xie Jiansong, Guenette Robert G, Li Shiqian, Smith Christopher E, Archunan Suresh, Agnihotram Manoj K, Sadhukhan Arghya, Kapoor Rajiv, Wilde Chris, Koirala Sajjan, De Sousa E Melo Felipe, Potts Patrick Ryan

MTA-cooperative PRMT5 inhibitors from cofactor-directed DNA-encoded library screens.

通过辅因子导向的DNA编码文库筛选得到的MTA协同PRMT5抑制剂

Andersson Jan, Cowland Sanne, Vestergaard Mikkel, Yang Yajing, Liu Siyuan, Fang Xie, Mukund Susmith, Ghimire-Rijal Sudipa, Carter Chris, Chung Grace, Jacso Tomas, Sarvary Ian, Hughes Paul E, Gouliaev Alex, Payton Marc, Belmontes Brian, Caenepeel Sean, Franch Thomas, Glad Sanne, Husemoen Birgitte, Nielsen Søren Jensby

From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy.

从 DNA 编码文库筛选到 AM-9747:一种具有强效口服体内疗效的 MTA 协同 PRMT5 抑制剂

Sarvary Ian, Vestergaard Mikkel, Moretti Loris, Andersson Jan, Peiró Cadahía Jorge, Cowland Sanne, Flagstad Thomas, Franch Thomas, Gouliaev Alex, Husemoen Gitte, Jacso Tomas, Kronborg Titi, Kuropatnicka Aleksandra, Nadali Anna, Madsen Mads, Nielsen So Ren, Pii David, Ryborg So Ren, Soede Camillia, Allen Jennifer R, Bourbeau Matthew, Li Kexue, Liu Qingyian, Lo Mei-Chu, Madoux Franck, Mardirossian Narbe, Moriguchi Jodi, Ngo Rachel, Peng Chi-Chi, Pettus Liping, Tamayo Nuria, Wang Paul, Kapoor Rajiv, Belmontes Brian, Caenepeel Sean, Hughes Paul, Liu Siyuan, Slemmons Katherine K, Yang Yajing, Xie Fang, Ghimire-Rijal Sudipa, Mukund Susmith, Glad Sanne

Safety and glycemic control with insulin degludec use in clinical practice: results from a 3-year Japanese post-marketing surveillance study

胰岛素德谷在临床实践中的安全性和血糖控制:一项为期3年的日本上市后监测研究结果

Murata, Takashi; Husemoen, Lise Lotte N; Nemoto, Satoko; Matsuhisa, Munehide

Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014-2019 from a US database: prescriber and patient characteristics

基于美国数据库的2014-2019年间2型糖尿病患者使用新型胰高血糖素样肽-1受体激动剂的模式:处方医生和患者特征

Lingvay, Ildiko; Aroda, Vanita R; Honoré, Julie Broe; Ersbøll, Anne S; Nystrup Husemoen, Lise Lotte; Jensen, Anders Boeck; Sommer Matthiessen, Kasper; Kosiborod, Mikhail Naum

Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population-based observational retrospective cohort study

2型糖尿病患者(无既往心血管疾病)治疗早期心血管危险因素:一项基于人群的观察性回顾性队列研究

Khunti, Kamlesh; Hertz, Christin L; Husemoen, Lise Lotte N; Mocevic, Emina; Nordsborg, Rikke B; Piltoft, Johanne S; Bain, Stephen C

All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK

英国一项队列研究:初次使用胰岛素治疗的2型糖尿病患者接受地特胰岛素或甘精胰岛素治疗后的全因死亡率和心血管死亡率

Husemoen, Lise Lotte Nystrup; Mørch, Lina S; Christensen, Per K; Hartvig, Niels V; Feher, Michael D

Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study

美国数据库研究:糖尿病患者开始使用速效胰岛素门冬胰岛素治疗后的血糖控制情况

Lane, Wendy; Faurby, Mads; Husemoen, Lise Lotte N; Markovich, Dmitriy L; Rathor, Naveen; De Block, Christophe

Understanding Patients' Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market

在自费市场中,了解患者对用于治疗2型糖尿病的双相胰岛素门冬胰岛素30/70注射笔的支付意愿

Murthy, Sreenivasa; Aneja, Pankaj; Asirvatham, Arthur Joseph; Husemoen, Lise Lotte N; Rhee, Nicolai A; Kesavadev, Jothydev